{"id":"https://openalex.org/W1985366832","doi":"https://doi.org/10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","title":"Chemotherapy for multiple myeloma","display_name":"Chemotherapy for multiple myeloma","publication_year":1984,"publication_date":"1984-02-01","ids":{"openalex":"https://openalex.org/W1985366832","doi":"https://doi.org/10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","mag":"1985366832","pmid":"https://pubmed.ncbi.nlm.nih.gov/6362819"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","doi":"https://doi.org/10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819840201%2953%3A3%3C583%3A%3AAID-CNCR2820530336%3E3.0.CO%3B2-1","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819840201%2953%3A3%3C583%3A%3AAID-CNCR2820530336%3E3.0.CO%3B2-1","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007796652","display_name":"Raymond Alexanian","orcid":"https://orcid.org/0000-0002-3030-7404","observed_orcids":["https://orcid.org/0000-0002-3030-7404"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond Alexanian","raw_affiliation_strings":["University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103138544","display_name":"Robert Dreicer","orcid":"https://orcid.org/0000-0002-0552-6912","observed_orcids":["https://orcid.org/0000-0002-0552-6912"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Dreicer","raw_affiliation_strings":["University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":5.3914,"has_fulltext":true,"cited_by_count":89,"citation_normalized_percentile":{"value":0.95838789,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"53","issue":"3","first_page":"583","last_page":"588"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.656000018119812},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.656000018119812},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9440000057220459},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.996999979019165},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.9940000176429749},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7820000052452087},{"id":"https://openalex.org/keywords/levamisole","display_name":"levamisole","score":0.9779999852180481},{"id":"https://openalex.org/keywords/remission-maintenance","display_name":"remission maintenance","score":0.9290000200271606},{"id":"https://openalex.org/keywords/survival-time","display_name":"survival time","score":0.5419999957084656},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8928400278091431},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.8627324104309082},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8128128051757812},{"id":"https://openalex.org/C2781325985","wikidata":"https://www.wikidata.org/wiki/Q417097","display_name":"Levamisole","level":2,"score":0.7813930511474609},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.7543920278549194},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.682344913482666},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6221621036529541},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5644856095314026},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5559341907501221},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.44291627407073975},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.43507158756256104},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.36194008588790894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.23016729950904846}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002330","descriptor_name":"Carmustine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007978","descriptor_name":"Levamisole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008558","descriptor_name":"Melphalan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","doi":"https://doi.org/10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819840201%2953%3A3%3C583%3A%3AAID-CNCR2820530336%3E3.0.CO%3B2-1","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:6362819","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6362819","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","doi":"https://doi.org/10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(19840201)53:3<583::aid-cncr2820530336>3.0.co;2-1","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819840201%2953%3A3%3C583%3A%3AAID-CNCR2820530336%3E3.0.CO%3B2-1","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8399999737739563,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1985366832.pdf","grobid_xml":"https://content.openalex.org/works/W1985366832.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W850470413","https://openalex.org/W1575224475","https://openalex.org/W1966912003","https://openalex.org/W1979300931","https://openalex.org/W2006382315","https://openalex.org/W2014698797","https://openalex.org/W2032602077","https://openalex.org/W2037355300","https://openalex.org/W2046649826","https://openalex.org/W2059403857","https://openalex.org/W2075220205","https://openalex.org/W2081457935","https://openalex.org/W2267464260","https://openalex.org/W2273737858","https://openalex.org/W2309741057","https://openalex.org/W2319141727","https://openalex.org/W2412468341","https://openalex.org/W2413440918","https://openalex.org/W4293241248"],"related_works":["https://openalex.org/W2037355300","https://openalex.org/W2099704297","https://openalex.org/W2093520755","https://openalex.org/W2040903318","https://openalex.org/W1989320836","https://openalex.org/W4237712222","https://openalex.org/W2465225878","https://openalex.org/W6997032980","https://openalex.org/W1872098847","https://openalex.org/W2000538996"],"abstract_inverted_index":{"The":[0,15,71],"effects":[1],"of":[2,68,73,87],"eight":[3],"different":[4],"drug":[5,51],"combinations":[6,52],"were":[7,22],"evaluated":[8,53],"in":[9,42,54,91,97],"256":[10],"patients":[11,93],"with":[12,94],"multiple":[13],"myeloma.":[14],"response":[16,43],"rate":[17,44],"and":[18,30,63],"time":[19,47],"to":[20,33,57,64],"remission":[21,76,89],"superior":[23],"from":[24,48],"regimens":[25],"that":[26],"added":[27],"both":[28],"vincristine":[29],"Adriamycin":[31],"(doxorubicin)":[32],"an":[34,55],"alkylating":[35],"agent-prednisone":[36],"combination.":[37],"There":[38],"was":[39],"no":[40],"improvement":[41],"or":[45],"survival":[46,81],"two":[49],"alternating":[50],"attempt":[56],"achieve":[58],"more":[59],"marked":[60,95],"tumor":[61],"reductions":[62,96],"delay":[65],"the":[66,85],"emergence":[67],"resistant":[69],"subclones.":[70],"addition":[72],"levamisole":[74],"during":[75],"maintenance":[77],"did":[78],"not":[79],"improve":[80],"time.":[82],"Results":[83],"supported":[84],"utility":[86],"unmaintained":[88],"follow-up":[90],"selected":[92],"myeloma":[98],"cell":[99],"mass.":[100]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}